MARC Record from marc_columbia

LEADER: 08425cam a22004934a 4500
001 5464659
005 20221110042402.0
008 041104t20062006nyua b 001 0 eng
010 $a 2004063122$z 2005050545
016 7 $a101258215$2DNLM
019 $a60516669
020 $a0071422803
029 1 $aNLM$b101258215
035 $a(OCoLC)ocm56982354
035 $a(NNC)5464659
035 $a5464659
040 $aDLC$cDLC$dBAKER$dCOU$dJDR$dC#P$dNLM$dMUQ$dHU6$dOrLoB-B
042 $apcc
050 00 $aRM300$b.G644 2006
060 00 $a2005 L-513
060 10 $aQV 4$bG6532 2006
082 00 $a615/.7$222
245 00 $aGoodman & Gilman's the pharmacological basis of therapeutics.
246 30 $aPharmacological basis of therapeutics
246 3 $aGoodman and Gilman's the pharmacological basis of therapeutics
250 $a11th ed. /$beditor, Laurence L. Brunton ; associate editors, John S. Lazo, Keith L. Parker.
260 $aNew York :$bMcGraw-Hill,$c[2006], ©2006.
300 $axxiii, 2021 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tPharmacokinetics and pharmacodynamics : the dynamics of drug absorption, distribution, action, and elimination /$rIain L. O. Buxton -- $g2.$tMembrane transporters and drug response /$rKathleen M. Giacomini and Yuichi Sugiyama -- $g3.$tDrug metabolism /$rFrank J. Gonzalez and Robert H. Tukey -- $g4.$tPharmacogenetics /$rMary V. Relling and Kathleen M. Giacomini -- $g5.$tThe science of drug therapy /$rJohn A. Oates -- $g6.$tNeurotransmission : the autonomic and somatic motor nervous systems /$rThomas C. Westfall and David P. Westfall -- $g7.$tMuscarinic receptor agonists and antagonists /$rJoan Heller Brown and Palmer Taylor -- $g8.$tAnticholinesterase agents /$rPalmer Taylor -- $g9.$tAgents acting at the neuromuscular junction and autonomic ganglia /$rPalmer Taylor -- $g10.$tAdrenergic agonists and antagonists /$rThomas C. Westfall and David P. Westfall -- $g11.$t5-Hydroxytryptamine (serotonin) : receptor agonists and antagonists /$rElaine Sanders-Bush and Steven E. Mayer -- $g12.$tNeurotransmission and the central nervous system /$rFloyd E. Bloom -- $g13.$tGeneral anesthetics /$rAlex S. Evers, C. Michael Crowder and Jeffrey R. Balser -- $g14.$tLocal anesthetics /$rWilliam A. Catterall and Ken Mackie -- $g15.$tTherapeutic gases : oxygen, carbon dioxide, nitric oxide, and helium /$rBrett A. Simon, Eric J. Moody and Roger A. Johns -- $g16.$tHypnotics and sedatives /$rDennis S. Charney, S. John Mihic and R. Adron Harris -- $g17.$tDrug therapy of depression and anxiety disorders /$rRoss J. Baldessarini -- $g18.$tPharmacotherapy of psychosis and mania /$rRoss J. Baldessarini and Frank I. Tarazi -- $g19.$tPharmacotherapy of the epilepsies /$rJames O. McNamara -- $g20.$tTreatment of central nervous system degenerative disorders /$rDavid G. Standaert and Anne B. Young -- $g21.$tOpioid analgesics /$rHoward B. Gutstein and Huda Akil -- $g22.$tEthanol /$rMichael F. Fleming, S. John Mihic and R. Adron Harris -- $g23.$tDrug addiction and drug abuse /$rCharles P. O'Brien -- $g24.$tHistamine, bradykinin, and their antagonists /$rRandal A. Skidegel and Ervin G. Erdos -- $g25.$tLipid-derived autacoids : eicosanoids and platelet-activating factor /$rEmer M. Smyth, Anne Burke and Garret A. FitzGerald -- $g26.$tAnalgesic-antipyretic agents; pharmacotherapy of gout /$rAnne Burke, Emer M. Smyth and Garret A. FitzGerald -- $g27.$tPharmacotherapy of asthma /$rBradley J. Undem -- $g28.$tDiuretics /$rEdwin K. Jackson -- $g29.$tVasopressin and other agents affecting the renal conservation of water /$rEdwin K. Jackson -- $g30.$tRenin and angiotensin /$rEdwin K. Jackson -- $g31.$tTreatment of myocardial ischemia /$rThomas Michel -- $g32.$tTherapy of hypertension /$rBrian B. Hoffman -- $g33.$tPharmacotherapy of congestive heart failure /$rThomas P. Rocco and James C. Fang -- $g34.$tAntiarrhythmic drugs /$rDan M. Roden -- $g35.$tDrug therapy for hypercholesterolemia and dyslipidemia /$rRobert W. Mahley and Thomas P. Bersot -- $g36.$tPharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease /$rWillemijntje A. Hoogerwerf and Pankaj Jay Pasricha -- $g37.$tTreatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease /$rPankaj Jay Pasricha -- $g38.$tPharmacotherapy of inflammatory bowel disease /$rJoseph H. Sellin and Pankaj Jay Pasricha -- $g39.$tChemotherapy of protozoal infections : malaria /$rTheresa A. Shapiro and Daniel E. Goldberg -- $g40.$tChemotherapy of protozoal infections : amebiasis, giardiasis, trichomoniasis, trypanosomiasis, leishmaniasis, and other protozoal infections /$rMargaret A. Phillips and Samuel L. Stanley, Jr. -- $g41.$tChemotherapy of helminth infections /$rAlex Loukas and Peter J. Hotez -- $g42.$tGeneral considerations of antimicrobial therapy /$rHenry F. Chambers -- $g43.$tSulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections /$rWilliam A. Petri, Jr. -- $g44.$tPencillins, cephalosoporins, and other [beta]-lactam antibiotics /$rWilliam A. Petri, Jr. -- $g45.$tAminoglycosides /$rHenry F. Chambers -- $g46.$tProtein synthesis inhibitors and miscellaneous antibacterial agents /$rHenry F. Chambers -- $g47.$tChemotherapy of tuberculosis, mycobacterium avium complex disease, and leprosy /$rWilliam A. Petri, Jr. -- $g48.$tAntifungal agents /$rJohn E. Bennett -- $g49.$tAntiviral agents (nonretroviral) /$rFrederick G. Hayden -- $g50.$tAntiretroviral agents and treatment of HIV infection /$rCharles Flexner -- $g51.$tAntineoplastic agents /$rBruce A. Chabner, Philip C. Amrein, Brian Druker, M. Dror Michaelson, Constantine S. Mitsiades, Paul E. Goss, David P. Ryan, Sumant Ramachandra, Paul G. Richardson, Jeffrey G. Supko and Wyndham H. Wilson -- $g52.$tImmunosuppressants, tolerogens, and immunostimulants /$rAlan M. Krensky, Flavio Vincenti and William M. Bennett -- $g53.$tHematopoietic agents : growth factors, minerals, and vitamins /$rKenneth Kaushansky and Thomas J. Kipps -- $g54.$tBlood coagulation and anticoagulant, thrombolytic, and antiplatlet drugs /$rPhilip W. Majerus and Douglas M. Tollefsen -- $g55.$tPituitary hormones and their hypothalamic releasing factors /$rKeith L. Parker and Bernard P. Schimmer -- $g56.$tThyroid and antithyroid drugs /$rAlan P. Farwell and Lewis E. Braverman -- $g57.$tEstrogens and progestins /$rDavid S. Loose and George M. Stancel -- $g58.$tAndrogens /$rPeter J. Snyder -- $g59.$tAdrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones /$rBernard P. Schimmer and Keith L. Parker -- $g60.$tInsulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas /$rStephen N. Davis -- $g61.$tAgents affecting mineral ion homeostasis and bone turnover /$rPeter A. Friedman -- $g62.$tDermatological pharmacology /$rLindy P. Fox, Hans F. Merk and David R. Bickers -- $g63.$tOcular pharmacology /$rJeffrey D. Henderer and Christopher J. Rapuano -- $g64.$tPrinciples of toxicology and treatment of poisoning /$rCurtis D. Klaassen -- $g65.$tHeavy metals and heavy-metal antagonists /$rCurtis D. Klaassen -- $gApp. I.$tPrinciples of prescription order writing and patient compliance /$rIain L. O. Buxton -- $gApp. II.$tDesign and optimization of dosage regimens; pharmacokinetic data /$rKenneth E. Thummel, Danny D. Shen, Nina Isoherranen and Helen E. Smith.
650 0 $aPharmacology.$0http://id.loc.gov/authorities/subjects/sh85100599
650 0 $aTherapeutics.$0http://id.loc.gov/authorities/subjects/sh85134723
650 12 $aPharmacology.$0https://id.nlm.nih.gov/mesh/D010600
650 22 $aDrug Therapy.$0https://id.nlm.nih.gov/mesh/D004358
650 6 $aPharmacologie.
650 6 $aThérapeutique.
700 1 $aGoodman, Louis S.$q(Louis Sanford),$d1906-2000.$0http://id.loc.gov/authorities/names/n80086280
700 1 $aGilman, Alfred,$d1908-1984.$0http://id.loc.gov/authorities/names/n80086279
700 1 $aBrunton, Laurence L.$0http://id.loc.gov/authorities/names/n2004017174
700 1 $aLazo, John S.$0http://id.loc.gov/authorities/names/n80165030
700 1 $aParker, Keith L.$0http://id.loc.gov/authorities/names/n2004017175
852 00 $boff,hsl$hRM121$i.P49 2006